Notably, it also increases APP processing (Shirey et al., 2009) and extends the lifespan of terminally-sick mice with neurodegenerative disease (Bradley et al., 2017), suggesting that M1 PAMs have the potential to improve cognition and to modify the underlying cause of Alzheimer's disease. This evidence concerns the gene APP and early-onset autosomal dominant Alzheimer disease.